Author

François Girodon

Observed names: F Girodon, F. GIRODON, F. Girodon, François Girodon, Francois Girodon, François Girodon, GIRODON, François, Girodon François, Girodon, F., Girodon, François

Institutions: Centre National de la Recherche Scientifique, Inserm, Université de Bourgogne, Laboratory of Excellence GR-Ex, CHU Dijon Bourgogne, Institut du Thorax, Université de Nantes, Nantes Université

Observed institutions: Conservatoire National des Arts et Métiers, Centre National de la Recherche Scientifique, Inserm, University of New Mexico, Université de Bourgogne, Université de Montpellier, University Hospital of Basel, Centre Hospitalier Universitaire de Bordeaux, Centre Hospitalier Universitaire de Nantes, Laboratory of Excellence GR-Ex, La Ligue Contre le Cancer, Centre Hospitalier Universitaire de Nîmes, Centre Hospitalier Universitaire d'Angers, CHU Dijon Bourgogne, Université Bourgogne Franche-Comté, Intergroupe Francophone du Myélome, Örebro University Hospital, Centre de recherche Translationnelle en Médecine moléculaire, Institut du Thorax, Institut des Biomolécules Max Mousseron, Institut des Maladies Génétiques Imagine, University of New Mexico Health Sciences Center, Université de Nantes, Laboratoire d'hématologie, Nantes Université

ORCID: 0000-0003-3151-1068

Observed ORCID: 0000-0003-3151-1068

OpenAlex ID: A5029918265

Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

2007 · Alexandre Theocharides, Marjorie Boissinot, et al. · Blood · 326

Impact of Trace Elements and Vitamin Supplementation on Immunity and Infections in Institutionalized Elderly Patients

1999 · François Girodon · Archives of Internal Medicine · 290

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

2012 · Francesco Passamonti, Jürgen Thiele, et al. · Blood · 277

PDF

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

2011 · Francesco Passamonti, Chiara Elena, et al. · Blood · 236

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

2006 · Eric Lippert, Marjorie Boissinot, et al. · Blood · 234

Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.

2004 · Pascal Mossuz, François Girodon, et al. · PubMed · 156

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution

2023 · Alba Rodriguez-Meira, Ruggiero Norfo, et al. · Nature Genetics · 155

PDF

Effect of Micronutrient Supplementation on Infection in Institutionalized Elderly Subjects: A Controlled Trial

1997 · François Girodon, Marie Lombard, et al. · Annals of Nutrition and Metabolism · 134

Genetic Basis of Congenital Erythrocytosis: Mutation Update and Online Databases

2013 · Celeste Bento, Melanie J. Percy, et al. · Human Mutation · 125

PDF

Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters.

1997 · F Girodon, D Blache, et al. · Journal of the American College of Nutrition · 122

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution

2014 · X Cabagnols, J P Defour, et al. · Leukemia · 115

Cohen syndrome is associated with major glycosylation defects

2013 · Laurence Duplomb, Sandrine Duvet, et al. · Human Molecular Genetics · 99

Presence of calreticulin mutations in JAK2-negative polycythemia vera

2014 · Julien Broséus, Ji-Hye Park, et al. · Blood · 98

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

2018 · Marion Lenglet, Florence Robriquet, et al. · Blood · 97

PDF

Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

2013 · J Broséus, T Alpermann, et al. · Leukemia · 95

PDF

Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)

2010 · M. Maynadie, F. Girodon, et al. · Haematologica · 92

PDF

HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms

2015 · Margaux Sevin, François Girodon, et al. · Mediators of Inflammation · 89

PDF

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis

2012 · J. Broseus, L. Florensa, et al. · Haematologica · 89

PDF

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

2021 · Damien Luque Paz, Jérémie Riou, et al. · Blood Advances · 80

Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population‐based study of 327 patients

2012 · Gilles Bonicelli, Khadija Abdulkarim, et al. · British Journal of Haematology · 80

AML transformation in 56 patients with Ph− MPD in two well defined populations

2008 · Khadija Abdulkarim, François Girodon, et al. · European Journal Of Haematology · 79

Usefulness of the eosin‐5′‐maleimide cytometric method as a first‐line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis

2007 · François Girodon, Loïc Garçon, et al. · British Journal of Haematology · 79

PDF

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

2019 · Emanuela Sant'Antonio, Paola Guglielmelli, et al. · American Journal of Hematology · 78

PDF

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

2008 · E. Lippert, F. Girodon, et al. · Haematologica · 78

PDF

The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera

2009 · D Olcaydu, R C Skoda, et al. · Leukemia · 72

Works count: 210

Citation count: 5,532

H-index: 42

I10-index: 90